Lexeo Therapeutics, Inc.
LXEO
$4.84
-$0.12-2.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.87M | -20.20M | -20.92M | -20.28M | -26.10M |
| Total Depreciation and Amortization | 556.00K | 546.00K | 538.00K | 530.00K | 510.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.71M | 2.71M | 2.70M | 2.71M | -285.00K |
| Change in Net Operating Assets | 2.00M | -4.21M | -2.40M | -12.51M | -1.34M |
| Cash from Operations | -17.60M | -21.14M | -20.08M | -29.55M | -27.22M |
| Capital Expenditure | -7.00K | -35.00K | 0.00 | -289.00K | -108.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.27M | 27.50M | -101.69M | 35.30M | -39.07M |
| Cash from Investing | 14.26M | 27.46M | -101.69M | 35.01M | -39.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -142.00K | -121.00K | -169.00K | -83.00K | -122.00K |
| Issuance of Common Stock | 25.32M | 2.60M | 153.77M | 135.00K | 80.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -779.00K | -25.00K | -9.83M | 0.00 | -6.92M |
| Cash from Financing | 24.40M | 2.45M | 143.77M | 52.00K | 72.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.07M | 8.77M | 22.00M | 5.52M | 6.57M |